F, R., C, N., F, C., C, G., M, G., G, V., . . . A, T. (2026). Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long-Term Follow-Up. Arthritis care & research. https://doi.org/10.1002/acr.80040
Chicago Style (17th ed.) CitationF, Ruffilli, et al. "Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long-Term Follow-Up." Arthritis Care & Research 2026. https://doi.org/10.1002/acr.80040.
MLA (9th ed.) CitationF, Ruffilli, et al. "Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long-Term Follow-Up." Arthritis Care & Research, 2026, https://doi.org/10.1002/acr.80040.